Updates
** Shares of ALS ALQ.AX fall as much as 9.3% to A$16, the lowest level since April 28
** Stock marks biggest intraday pct loss since September 19, 2024
** ALQ among top losers on ASX 200 benchmark
** Laboratory testing services provider, on Tuesday, in its FY25 report announced A$350 mln ($225.54 mln ) equity raising to fund developments of its four key laboratories
** Jefferies downgrades stock to "hold" from "buy", trims PT to A$18.2 from A$18.8; finds equity raising a surprise and perhaps could have been internally funded to avoid share dilution
** Morningstar cuts PT to A$19.7 from A$20; adding that immediate repayment of high-interest variable debt should dampen EPS dilution in FY26
** Stock up 8.1% YTD
($1 = 1.5518 Australian dollars)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.